1- Senior Resident of Neurosurgery, Department of Neurosurgery, Armed Forces Medical College, Pune, India
2- Professor of Neurosurgery, Department of Neurosurgery, Armed Forces Medical College, Pune, India , subir.dr@gmail.com
Abstract: (819 Views)
Background and Importance: Skull base osteomyelitis (SBO) is a complex disease process often confused with malignancy due to clinical and radiological masquerade. Extensive changes have recently occurred in the clinical course and management of the disease, attributed to improvements in neurosurgical procedures, diagnostic modalities, and the introduction of new antibiotics and management techniques thus reducing the associated morbidities and mortalities. However, SBO continues to pose a major challenge in the form of early diagnosis and management and can be the cause of devastating complications and high fatality associated with the disease.
Case Presentation: Here we provide the clinical profile, investigation, management, and outcome of 5 cases of SBO, all of whom were thoroughly examined for the neurological deficit, complete blood count, inflammatory markers, and radiographic imaging. Biopsy and microbiological culture reports were collected and patients were followed up.
Conclusion: Early diagnosis and culture-specific antibiotic treatment have been shown to provide good outcomes. Due to its rarity, large case series of SBO are insufficiently found in the literature.
Article number: 31
Full Text [PDF 2355 kb]
(253 Downloads)
| |
Full Text (HTML) (343 Views)
- Skull base osteomyelitis (SBO) is a rare and life-threatening disease, often characterized by multiple cranial nerve palsies.
- There is a need to differentiate it from other conditions such as brain stem gliomas, and multiple sclerosis.
- Early diagnosis and culture-specific treatments have a good prognosis.
- A high index of suspicion should be kept in immunocompromised patients with multiple cranial nerve palsy.
Type of Study:
Case report |
Subject:
Skull Base